| Diphenhydramine | ||||||||||||
| Ethanolamine derivitive and H-1 receptor antagonist which acts on blood vessels, GI and respiratory systems by competeing with histamine for h-1 receptor site. Decreases allergic response by blockade of histamine. | ||||||||||||
| Indications: Allergic Reaction/Anaphylaxis |
||||||||||||
| Common Side Effects: Dizziness, drowsiness, urinary retention. Potentially Lethal Side Effects: Seizure, Thrombocytopenia, agranulocytosis, hemolytic anemia, anaphylaxis. |
||||||||||||
| Contraindications: Hypersensitivity to H-1 receptor antagonists, acute asthma attack, lower repiratory tract disease. |
||||||||||||
| Adult dosing*: Mild to Moderate Allergic Reaction: IV/IM: 25mg Severe Allergic Reaction/Anaphylaxis: IV/IM: 50mg |
||||||||||||
| Pediatric dosing: Allergic Reaction/Anaphylaxis IV/IM: 1mg/kg slow push, prn Max 50mg |
||||||||||||
| Notes: - Expect a low BP to be present with anaphylaxis and severe allergic reaction. If BP not decreased, then another cause is likely. - IM onset may take up to 0.5 hour, IV onset immediate. Both have duration of 4-7 hours. - In lower airway conditions with increased secretions, diphenhydramine may cause thickening of secretions, thus complicating pre-existing condition. Decreased level of consciousness may cause compromise of a protected airway. |
||||||||||||